Correlation Between Vyne Therapeutics and Upstream Bio,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vyne Therapeutics and Upstream Bio, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vyne Therapeutics and Upstream Bio, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vyne Therapeutics and Upstream Bio,, you can compare the effects of market volatilities on Vyne Therapeutics and Upstream Bio, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vyne Therapeutics with a short position of Upstream Bio,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vyne Therapeutics and Upstream Bio,.

Diversification Opportunities for Vyne Therapeutics and Upstream Bio,

0.8
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Vyne and Upstream is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Vyne Therapeutics and Upstream Bio, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Upstream Bio, and Vyne Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vyne Therapeutics are associated (or correlated) with Upstream Bio,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Upstream Bio, has no effect on the direction of Vyne Therapeutics i.e., Vyne Therapeutics and Upstream Bio, go up and down completely randomly.

Pair Corralation between Vyne Therapeutics and Upstream Bio,

Given the investment horizon of 90 days Vyne Therapeutics is expected to generate 2.22 times less return on investment than Upstream Bio,. In addition to that, Vyne Therapeutics is 1.02 times more volatile than Upstream Bio,. It trades about 0.03 of its total potential returns per unit of risk. Upstream Bio, is currently generating about 0.06 per unit of volatility. If you would invest  1,700  in Upstream Bio, on August 27, 2024 and sell it today you would earn a total of  119.00  from holding Upstream Bio, or generate 7.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy6.65%
ValuesDaily Returns

Vyne Therapeutics  vs.  Upstream Bio,

 Performance 
       Timeline  
Vyne Therapeutics 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Vyne Therapeutics are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Vyne Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.
Upstream Bio, 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Upstream Bio, are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, Upstream Bio, sustained solid returns over the last few months and may actually be approaching a breakup point.

Vyne Therapeutics and Upstream Bio, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vyne Therapeutics and Upstream Bio,

The main advantage of trading using opposite Vyne Therapeutics and Upstream Bio, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vyne Therapeutics position performs unexpectedly, Upstream Bio, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Upstream Bio, will offset losses from the drop in Upstream Bio,'s long position.
The idea behind Vyne Therapeutics and Upstream Bio, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing